Pharmacological characterization of a nociceptin receptor from zebrafish (Danio rerio)

Journal of Molecular Endocrinology

Volumn 46, Issue 2, 2011, Pages 111-123

  Rivas Boyero, Ángel A ^a   Herrero Turrión, M Javier ^b   Gonzalez Nunez, Veronica ^a,b   Sánchez Simón, Fátima Macho ^a,b   Barreto Valer, Katherine ^a,b   Rodríguez, Raquel E ^a,b  

^a UNIVERSITY OF SALAMANCA   (Spain)

^b UNIVERSITY OF SALAMANCA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

BREMAZOCINE; COMPLEMENTARY DNA; DYNORPHIN A; GUANOSINE 5' O (3 THIOTRIPHOSPHATE); KAPPA OPIATE RECEPTOR; KAPPA OPIATE RECEPTOR ANTAGONIST; LIGAND; MESSENGER RNA; NALOXONE; NOCICEPTIN; NOCICEPTIN RECEPTOR; NORBINALTORPHIMINE; SULFUR 35; TRITIUM;

AMINO ACID SEQUENCE; ARTICLE; BINDING AFFINITY; CELL STRAIN HEK293; CENTRAL NERVOUS SYSTEM; EVOLUTION; GENE EXPRESSION; GILL; HUMAN; HUMAN CELL; ISOTOPE LABELING; LIVER; MOLECULAR CLONING; MUSCLE; NEUROPHARMACOLOGY; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; ZEBRA FISH;

AMINO ACID SEQUENCE; ANIMALS; BRAIN CHEMISTRY; CLONING, MOLECULAR; DNA, COMPLEMENTARY; GENE EXPRESSION; GILLS; GUANOSINE 5'-O-(3-THIOTRIPHOSPHATE); HEK293 CELLS; HUMANS; KINETICS; LIVER; MODELS, ANIMAL; MOLECULAR SEQUENCE DATA; OPIOID PEPTIDES; PHYLOGENY; PROTEIN BINDING; RECEPTORS, OPIOID; RECEPTORS, OPIOID, KAPPA; RECOMBINANT PROTEINS; SEQUENCE ALIGNMENT; ZEBRAFISH;

EID: 79953701927     PISSN: 09525041     EISSN: 14796813     Source Type: Journal    
DOI: 10.1530/JME-10-0130     Document Type: Article

References (52)

1. Barrallo A, Malvar FG, Gonzalez R, Rodriguez RE & Traynor JR 1998 Cloning and characterization of a δ opioid receptor from zebrafish. Biochemical Society Transactions 26 S360. (doi:10.1042/bst026s360)
2. Befort K, Tabbara L, Kling D, Maigret B & Kieffer BL 1996 Role of aromatic transmembrane residues of the delta-opioid receptor in ligand recognition. Journal of Biological Chemistry 271 10161-10168. (doi:10.1074/jbc.271.17.10161)
3. Bunzow JR, Saez C, Mortrud M, Bouvier C, Williams JT, Low M & Grandy DK 1994 Molecular cloning and tissue distribution of a putative member of the rat opioid receptor gene family that is not a mu, delta or kappa opioid receptor type. FEBS Letters 347 284-288. (doi:10.1016/0014-5793(94)00561-3)
4. Butour JL, Moisand C, Mazarguil H, Mollereau C & Meunier JC 1997 Recognition and activation of the opioid receptor-like ORL 1 receptor by nociceptin, nociceptin analogs and opioids. European Journal of Pharmacology 321 97-103. (doi:10.1016/S0014-2999 (96)00919-3)
5. Chavkin C & Goldstein A 1981 Specific receptor for the opioid peptide dynorphin: structure-activity relationships. PNAS 78 6543-6547. (doi:10.1073/pnas.78.10.6543)
6. Chen Y, Fan Y, Liu J, Mestek A, Tian M, Kozak CA & Yu L 1994 Molecular cloning, tissue distribution and chromosomal localization of a novel member of the opioid receptor gene family. FEBS Letters 347 279-283. (doi:10.1016/0014-5793(94)00560-5)
7. Cheng Y & Prusoff WH 1973 Relationship between the inhibition constant (K1) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reaction. Biochemical Pharmacology 22 3099-3108. (doi:10.1016/0006-2952(73)90196-2)
8. Chiou LC, Liao YY, Fan PC, Kuo PH, Wang CH, Riemer C & Prinssen EP 2007 Nociceptin/orphanin FQ peptide receptors: pharmacology and clinical implications. Current Drug Targets 8 117-135. (doi:10.2174/138945007779315605)
9. Danielson PB, Hoversten MT, Fitzpatrick M, Schreck C, Akil H & Dores RM 2001 Sturgeon orphanin, a molecular "fossil" that bridges the gap between the opioids and orphanin FQ/nociceptin. Journal of Biological Chemistry 276 22114-22119. (doi:10.1074/jbc. M011741200)
10. Dooley CT & Houghten RA 2000 Orphanin FQ/nociceptin receptor binding studies. Peptides 21 949-960. (doi:10.1016/S0196-9781(00) 00231-X)
11. Dores RM, Lecaude S, Bauer D & Danielson PB 2002 Analyzing the evolution of the opioid/orphanin gene family. Mass Spectrometry Reviews 21 220-243. (doi:10.1002/mas.10029)
12. Dumont M & Lemaire S 1998 Characterization of the high affinity [3H]nociceptin binding site in membrane preparations of rat heart: correlations with the non-opioid dynorphin binding site. Journal of Molecular and Cellular Cardiology 30 2751-2760. (doi:10. 1006/jmcc.1998.0838)
13. Fukuda K, Kato S, Mori K, Nishi M, Takeshima H, Iwabe N, Miyata T, Houtani T & Sugimoto T 1994 cDNA cloning and regional distribution of a novel member of the opioid receptor family. FEBS Letters 343 42-46. (doi:10.1016/0014-5793(94)80603-9)
14. Gonzalez-Nunez V & Rodriguez RE 2009 The zebrafish: a model to study the endogenous mechanisms of pain. ILAR Journal 50 373-386.
15. Gonzalez-Nunez V, Gonzalez-Sarmiento R & Rodriguez RE 2003 Cloning and characterization of a full-length pronociceptin in zebrafish: evidence of the existence of two different nociceptin sequences in the same precursor. Biochimica et Biophysica Acta 1629 114-118. (doi:10.1016/j.bbaexp.2003.08.001)
16. Gonzalez-Nunez V, Barrallo A, Traynor JR & Rodriguez RE 2006 Characterization of opioid-binding sites in zebrafish brain. Journal of Pharmacology and Experimental Therapeutics 316 900-904. (doi:10.1124/jpet.105.093492)
17. Hashiba E, Lambert DG, Farkas J, Toth G & Smith G 2002 Comparison of the binding of [(3)H]nociceptin/orphaninFQ(1-13)NH(2), [(3)H]nociceptin/orphaninFQ(1-17)OH and [(125)I]Tyr(14) nociceptin/orphaninFQ(1-17)OH to recombinant human and native rat cerebrocortical nociceptin/orphanin FQ receptors. Neuroscience Letters 328 5-8. (doi:10.1016/S0304-3940(02)00259-8)
18. Herrero-Turrion MJ & Rodriguez RE 2008 Bioinformatic analysis of the origin, sequence and diversification of mu opioid receptors in vertebrates. Molecular Phylogenetics and Evolution 49 877-892. (doi:10.1016/j.ympev.2008.09.016)
19. Kam KW, New DC & Wong YH 2002 Constitutive activation of the opioid receptor-like (ORL1) receptor by mutation of Asn133 to tryptophan in the third transmembrane region. Journal of Neurochemistry 831461-1470. (doi:10.1046/j.1471-4159.2002.01231.x)
20. Lachowicz JE, Shen Y, Monsma FJ Jr & Sibley DR 1995 Molecular cloning of a novel G protein-coupled receptor related to the opiate receptor family. Journal of Neurochemistry 64 34-40. (doi:10.1046/j. 1471-4159.1995.64010034.x)
21. Lapalu S, Moisand C, Mazarguil H, Cambois G, Mollereau C & Meunier JC 1997 Comparison of the structure-activity relationships of nociceptin and dynorphin A using chimeric peptides. FEBS Letters 417 333-336. (doi:10.1016/S0014-5793(97)01318-5)
22. Lieschke GJ & Currie PD 2007 Animal models of human disease: zebrafish swim into view. Nature Reviews. Genetics 8 353-367. (doi:10.1038/nrg2091)
23. McClendon J, Lecaude S, Dores AR & Dores RM 2010 Evolution of the opioid/ORL-1 receptor gene family. Annals of the New York Academy of Sciences 1200 85-94. (doi:10.1111/j.1749-6632.2010.05515.x)
24. Meng F, Taylor LP, Hoversten MT, Ueda Y, Ardati A, Reinscheid RK, Monsma FJ, Watson SJ, Civelli O & Akil H 1996 Moving from the orphanin FQ receptor to an opioid receptor using four point mutations. Journal of Biological Chemistry 271 32016-32020. (doi:10.1074/jbc.271.50.32016)
25. Meng F, Ueda Y, Hoversten MT, Taylor LP, Reinscheid RK, Monsma FJ, Watson SJ, Civelli O & Akil H 1998 Creating a functional opioid alkaloid binding site in the orphanin FQ receptor through site-directed mutagenesis. Molecular Pharmacology 53 772-777.
26. Metzger TG & Ferguson DM 1995 On the role of extracellular loops of opioid receptors in conferring ligand selectivity. FEBS Letters 375 1-4. (doi:10.1016/0014-5793(95)01185-H)
27. Meunier JC 1997 Nociceptin/orphanin FQ and the opioid receptorlike ORL1 receptor. European Journal of Pharmacology 340 1-15. (doi:10.1016/S0014-2999(97)01411-8)
28. Meunier JC, Mollereau C, Toll L, Suaudeau C, Moisand C, Alvinerie P, Butour JL, Guillemot JC, Ferrara P, Monsarrat B et al. 1995 Isolation and structure of the endogenous agonist of opioid receptor-like ORL1 receptor. Nature 377 532-535. (doi:10.1038/ 377532a0)
29. Mogil JS & Pasternak GW 2001 The molecular and behavioral pharmacology of the orphanin FQ/nociceptin peptide and receptor family. Pharmacological Reviews 53 381-415.
30. Mollereau C & Mouledous L 2000 Tissue distribution of the opioid receptor-like (ORL1) receptor. Peptides 21 907-917. (doi:10.1016/ S0196-9781(00)00227-8)
31. Mollereau C, Parmentier M, Mailleux P, Butour JL, Moisand C, Chalon P, Caput D, Vassart G & Meunier JC 1994 ORL1, a novel member of the opioid receptor family. Cloning, functional expression and localization. FEBS Letters 341 33-38. (doi:10.1016/0014-5793(94) 80235-1)
32. Mollereau C, Moisand C, Butour JL, Parmentier M & Meunier JC 1996 Replacement of Gln280 by His in TM6 of the human ORL1 receptor increases affinity but reduces intrinsic activity of opioids. FEBS Letters 395 17-21. (doi:10.1016/0014-5793(96) 00993-3)
33. Mollereau C, Mouledous L, Lapalu S, Cambois G, Moisand C, Butour JL & Meunier JC 1999 Distinct mechanisms for activation of the opioid receptor-like 1 and kappa-opioid receptors by nociceptin and dynorphin A. Molecular Pharmacology 55 324-331.
34. Mouledous L, Topham CM, Moisand C, Mollereau C & Meunier JC 2000 Functional inactivation of the nociceptin receptor by alanine substitution of glutamine 286 at the C terminus of transmembrane segment VI: evidence from a site-directed mutagenesis study of the ORL1 receptor transmembrane-binding domain. Molecular Pharmacology 57 495-502.
35. New DC & Wong YH 2002 The ORL1 receptor: molecular pharmacology and signalling mechanisms. Neurosignals 11 197-212. (doi:10.1159/000065432)
36. Nishi M, Takeshima H, Fukuda K, Kato S & Mori K 1993 cDNA cloning and pharmacological characterization of an opioid receptor with high affinities for kappa-subtype-selective ligands. FEBS Letters 330 77-80. (doi:10.1016/0014-5793(93)80923-I)
37. Osinski MA, Pampusch MS, Murtaugh MP & Brown DR 1999 Cloning, expression and functional role of a nociceptin/orphanin FQ receptor in the porcine gastrointestinal tract. European Journal of Pharmacology 365 281-289. (doi:10.1016/S0014-2999(98)00869-3)
38. Pan YX, Xu J & Pasternak GW 1996 Structure and characterization of the gene encoding a mouse kappa3-related opioid receptor. Gene 171 255-260. (doi:10.1016/0378-1119(95)00890-X)
39. Pinal-Seoane N, Martin IR, Gonzalez-Nunez V, de Velasco EM, Alvarez FA, Sarmiento RG & Rodriguez RE 2006 Characterization of a new duplicate delta-opioid receptor from zebrafish. Journal of Molecular Endocrinology 37 391-403. (doi:10.1677/jme.1.02136)
40. Reinscheid RK, Nothacker HP, Bourson A, Ardati A, Henningsen RA, Bunzow JR, Grandy DK, Langen H, Monsma FJ Jr & Civelli O 1995 Orphanin FQ: a neuropeptide that activates an opioidlike G protein-coupled receptor. Science 270 792-794. (doi:10.1126/ science.270.5237.792)
41. Reinscheid RK, Ardati A, Monsma FJ Jr & Civelli O 1996 Structure- activity relationship studies on the novel neuropeptide orphanin FQ. Journal of Biological Chemistry 271 14163-14168. (doi:10.1074/ jbc.271.24.14163)
42. Rizzi A, Calo G, Trevisani M, Tognetto M, Fabbri L, Mapp C, Guerrini R, Salvadori S, Regoli D & Geppetti P 1999 Nociceptin receptor activation inhibits tachykinergic non adrenergic non cholinergic contraction of guinea pig isolated bronchus. Life Sciences 64 L157-L163. (doi:10.1016/S0024-3205(99)00045-4)
43. Sanchez-Simon FM & Rodriguez RE 2008 Developmental expression and distribution of opioid receptors in zebrafish. Neuroscience 151 129-137. (doi:10.1016/j.neuroscience.2007.09.086)
44. Stevens CW, Brasel CM & Mohan S 2007 Cloning and bioinformatics of amphibian mu, delta, kappa, and nociceptin opioid receptors expressed in brain tissue: evidence for opioid receptor divergence in mammals. Neuroscience Letters 419 189-194. (doi:10.1016/j.neulet. 2007.04.014)
45. Tamura K, Dudley J, Nei M & Kumar S 2007 MEGA4: Molecular Evolutionary Genetics Analysis (MEGA) software version 4.0. Molecular Biology and Evolution 24 1596-1599. (doi:10.1093/molbev/ msm092)
46. Thompson JD, Higgins DG & Gibson TJ 1994 CLUSTALW: improving the sensitivity of progressive multiple sequence alignment through sequence weighting, position-specific gap penalties and weight matrix choice. Nucleic Acids Research 22 4673-4680. (doi:10.1093/ nar/22.22.4673)
47. Vincent B, Mouledous L, Bes B, Mazarguil H, Meunier JC, Milon A & Demange P 2008 Description of the low-affinity interaction between nociceptin and the second extracellular loop of its receptor by fluorescence and NMR spectroscopies. Journal of Peptide Science 14 1183-1194. (doi:10.1002/psc.1057)
48. Waldhoer M, Bartlett SE & Whistler JL 2004 Opioid receptors. Annual Reviews of Biochemistry 73 953-990. (doi:10.1146/annurev.biochem. 73.011303.073940)
49. Walthers EA, Bradford CS & Moore FL 2005 Cloning, pharmacological characterization and tissue distribution of an ORL1 opioid receptor from an amphibian, the rough-skinned newt Taricha granulosa. Journal of Molecular Endocrinology 34 247-256. (doi:10.1677/jme.1. 01687)
50. Wang JB, Johnson PS, Imai Y, Persico AM, Ozenberger BA, Eppler CM & Uhl GR 1994 cDNA cloning of an orphan opiate receptor gene family member and its splice variant. FEBS Letters 348 75-79. (doi:10.1016/0014-5793(94)00557-5)
51. Wick MJ, Minnerath SR, Lin X, Elde R, Law PY & Loh HH 1994 Isolation of a novel cDNA encoding a putative membrane receptor with high homology to the cloned mu, delta, and kappa opioid receptors. Brain Research. Molecular Brain Research 27 37-44. (doi:10. 1016/0169-328X(94)90181-3)
52. Zon LI & Peterson RT 2005 In vivo drug discovery in the zebrafish. Nature Reviews. Drug Discovery 4 35-44. (doi:10.1038/nrd1606)